Douglas S. Compton

3.0k total citations · 1 hit paper
24 papers, 2.5k citations indexed

About

Douglas S. Compton is a scholar working on Surgery, Endocrine and Autonomic Systems and Organic Chemistry. According to data from OpenAlex, Douglas S. Compton has authored 24 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Endocrine and Autonomic Systems and 6 papers in Organic Chemistry. Recurrent topics in Douglas S. Compton's work include Cholesterol and Lipid Metabolism (10 papers), Regulation of Appetite and Obesity (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Douglas S. Compton is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Regulation of Appetite and Obesity (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Douglas S. Compton collaborates with scholars based in United Kingdom, United States and China. Douglas S. Compton's co-authors include Margaret van Heek, Harry R. Davis, Edmund J. Sybertz, Lizbeth Hoos, Catherine D. Strader, Ahmad Fawzi, Constance Farley, M P Graziano, Kevin B. Alton and Glen Tetzloff and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Douglas S. Compton

24 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diet-induced obese mice develop peripheral, but not central, resistance to leptin.

1997 649 citations Margaret van Heek, Douglas S. Compton et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Douglas S. Compton

Since Specialization

Citations

This map shows the geographic impact of Douglas S. Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Compton more than expected).

Fields of papers citing papers by Douglas S. Compton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas S. Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Compton. The network helps show where Douglas S. Compton may publish in the future.

Co-authorship network of co-authors of Douglas S. Compton

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Compton. A scholar is included among the top collaborators of Douglas S. Compton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Compton. Douglas S. Compton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dehydration-anorexia derives from a reduction in meal size, but not meal number 2011 ·Physiology & Behavior ·Christina N. Boyle, (unknown), Douglas S. Compton, Alan G. Watts	23
2	Relationship among Brain and Blood Glucose Levels and Spontaneous and Glucoprivic Feeding 2009 ·Journal of Neuroscience ·Ambrose A. Dunn-Meynell, Nicole M. Sanders, Douglas S. Compton, Thomas Becker, Jun‐ichi Eiki, Bei B. Zhang, Barry E. Levin	113
3	Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats 2003 ·British Journal of Pharmacology ·Margaret van Heek, Constance Farley, Douglas S. Compton, Lizbeth Hoos, April Smith‐Torhan, Harry R. Davis	51
4	The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption 2002 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·S. Altmann, Harry R. Davis, Xiaorui Yao, Maureen Laverty, Douglas S. Compton, Li-Ji Zhu, James H. Crona, Mary Ann Caplen, Lizbeth Hoos, Glen Tetzloff, Tony Priestley, Duane A. Burnett, Catherine D. Strader, Michael P. Graziano	124
5	The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys 2001 ·European Journal of Pharmacology ·Margaret van Heek, Douglas S. Compton, Harry R. Davis	109
6	Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function 2001 ·British Journal of Pharmacology ·Margaret van Heek, Constance Farley, Douglas S. Compton, Lizbeth Hoos, Harry R. Davis	173
7	Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout Mice 2001 ·Arteriosclerosis Thrombosis and Vascular Biology ·Harry R. Davis, Douglas S. Compton, Lizbeth Hoos, Glen Tetzloff	180
8	Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663 2000 ·British Journal of Pharmacology ·Margaret van Heek, Constance Farley, Douglas S. Compton, Lizbeth Hoos, Kevin B. Alton, Edmund J. Sybertz, Harry R. Davis	265
9	The potent cholesterol absorption inhibitor, ezetimibe, is glucuronidated in the intestine, localizes to the intestine, and circulates enterohepatically 2000 ·Atherosclerosis ·Margaret van Heek, Constance Farley, Douglas S. Compton, Lizbeth Hoos, Kevin B. Alton, Edmund J. Sybertz, Harry R. Davis	9
10	The novel cholesterol absorption inhibitor, ezetimibe, selectively inhibits the intestinal absorption of free cholesterol in the presence and absence of exocrine pancreatic function 2000 ·Atherosclerosis ·Margaret van Heek, Constance Farley, Douglas S. Compton, Lizbeth Hoos, Harry R. Davis	6
11	The cholesterol absorption inhibitor ezetimibe inhibits the development of atherosclerosis in apo E knockout (−/−) mice fed low fat and western diets 2000 ·Atherosclerosis ·Harry R. Davis, Douglas S. Compton, Lizbeth Hoos, Glen Tetzloff	6
12	Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats 1998 ·Obesity Research ·Harry R. Davis, Deborra Mullins, Jesse M. Pines, Lizbeth Hoos, (unknown), Douglas S. Compton, Michael P. Graziano, Edmund J. Sybertz, Catherine D. Strader, Margaret van Heek	49
13	Diet-induced obese mice develop peripheral, but not central, resistance to leptin. breakdown → 1997 ·Journal of Clinical Investigation ·Margaret van Heek, Douglas S. Compton, (unknown), (unknown), Ahmad Fawzi, M P Graziano, Edmund J. Sybertz, Catherine D. Strader, (unknown)	649
14	In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Margaret van Heek, (unknown), Douglas S. Compton, Robbie L. McLeod, Nathan Yumibe, Kevin B. Alton, Edmund J. Sybertz, Harry R. Davis	240
15	The Relationship of Tissue Localization, Distribution and Turnover to Feeding After Intraperitoneal¹²⁵I-Leptin Administration toob/obanddb/dbMice 1996 ·Hormone and Metabolic Research ·Margaret van Heek, Donald E. Mullins, Michael D. Wirth, (unknown), Ahmad Fawzi, Douglas S. Compton, Christopher France, Lizbeth Hoos, R Casale, Edmund J. Sybertz, Catherine D. Strader, (unknown)	45
16	Intracerebroventricular Injection of Leptin Increases Thermogenesis and Mobilizes Fat Metabolism inob/obMice 1996 ·Hormone and Metabolic Research ·Jeong Seok Hwa, Lorraine Ghibaudi, Douglas S. Compton, Ahmad Fawzi, Catherine D. Strader	113
17	ChemInform Abstract: (‐)‐SCH 57939: Synthesis and Pharmacological Properties of a Potent, Metabolically Stable Cholesterol Absorption Inhibitor. 1996 ·ChemInform ·Michael P. Kirkup, Razia Rizvi, (unknown), Sundeep Dugar, (unknown), Stuart W. McCombie, Sue‐Ing Lin, Nathan Yumibe, Keith Huie, Margaret van Heek, Douglas S. Compton, Harry R. Davis, Andrew T. McPhail	3
18	(−)-SCH 57939: synthesis and pharmacological properties of a potent, metabolically stable cholesterol absorption inhibitor 1996 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Kirkup, Razia Rizvi, Bandarpalle B. Shankar, Sundeep Dugar, John W. Clader, Stuart W. McCombie, Sue‐Ing Lin, Nathan Yumibe, Keith Huie, Margaret van Heek, Douglas S. Compton, Harry R. Davis, Andrew T. McPhail	20
19	Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461 1995 ·Atherosclerosis ·Brian Salisbury, Harry R. Davis, Robert E. Burrier, Duane A. Burnett, (unknown), Mary Ann Caplen, Anthony Clemmons, Douglas S. Compton, Lizbeth Hoos, (unknown), Robin Schnitzer‐Polokoff, (unknown), Blair Weig, (unknown), John W. Clader, Edmund J. Sybertz	94
20	Effect of the cholesterol absorption inhibitor SCH48461 in combination with the HMG-CoA reductase inhibitor lovastatin in rabbits, dogs and rhesus monkeys 1994 ·Atherosclerosis ·Harry R. Davis, R.W. Watkins, Brian Salisbury, Douglas S. Compton, Edmund J. Sybertz, Robert E. Burrier	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact